143 related articles for article (PubMed ID: 14529628)
21. Conformational Entropy as a Determinant of the Thermodynamic Stability of the p53 Core Domain.
Bej A; Rasquinha JA; Mukherjee S
Biochemistry; 2018 Nov; 57(44):6265-6269. PubMed ID: 30362715
[TBL] [Abstract][Full Text] [Related]
22. Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide: implications for "mutant conformation".
Friedler A; DeDecker BS; Freund SM; Blair C; Rüdiger S; Fersht AR
J Mol Biol; 2004 Feb; 336(1):187-96. PubMed ID: 14741214
[TBL] [Abstract][Full Text] [Related]
23. Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.
Kovachev PS; Banerjee D; Rangel LP; Eriksson J; Pedrote MM; Martins-Dinis MMDC; Edwards K; Cordeiro Y; Silva JL; Sanyal S
J Biol Chem; 2017 Jun; 292(22):9345-9357. PubMed ID: 28420731
[TBL] [Abstract][Full Text] [Related]
24. Correlation of levels of folded recombinant p53 in escherichia coli with thermodynamic stability in vitro.
Mayer S; Rüdiger S; Ang HC; Joerger AC; Fersht AR
J Mol Biol; 2007 Sep; 372(1):268-76. PubMed ID: 17631895
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the p53-rescue drug CP-31398 in vitro and in living cells.
Rippin TM; Bykov VJ; Freund SM; Selivanova G; Wiman KG; Fersht AR
Oncogene; 2002 Mar; 21(14):2119-29. PubMed ID: 11948395
[TBL] [Abstract][Full Text] [Related]
26. A fast method for predicting amino acid mutations that lead to unfolding.
Wright JD; Lim C
Protein Eng; 2001 Jul; 14(7):479-86. PubMed ID: 11522921
[TBL] [Abstract][Full Text] [Related]
27. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
28. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
Lubin DJ; Butler JS; Loh SN
J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
[TBL] [Abstract][Full Text] [Related]
29. Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.
Stavridi ES; Chehab NH; Caruso LC; Halazonetis TD
Protein Sci; 1999 Sep; 8(9):1773-9. PubMed ID: 10493578
[TBL] [Abstract][Full Text] [Related]
30. Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutant.
Barakat K; Issack BB; Stepanova M; Tuszynski J
PLoS One; 2011; 6(11):e27651. PubMed ID: 22110706
[TBL] [Abstract][Full Text] [Related]
31. Specific DNA binding by different classes of human p53 mutants.
Rolley N; Butcher S; Milner J
Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
[TBL] [Abstract][Full Text] [Related]
32. Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain.
Wright JD; Noskov SY; Lim C
Nucleic Acids Res; 2002 Apr; 30(7):1563-74. PubMed ID: 11917017
[TBL] [Abstract][Full Text] [Related]
33. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
[TBL] [Abstract][Full Text] [Related]
34. A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.
Friedler A; Hansson LO; Veprintsev DB; Freund SM; Rippin TM; Nikolova PV; Proctor MR; Rüdiger S; Fersht AR
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):937-42. PubMed ID: 11782540
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.
Bullock AN; Henckel J; Fersht AR
Oncogene; 2000 Mar; 19(10):1245-56. PubMed ID: 10713666
[TBL] [Abstract][Full Text] [Related]
36. Insights into the intramolecular coupling between the N- and C-domains of troponin C derived from high-pressure, fluorescence, nuclear magnetic resonance, and small-angle X-ray scattering studies.
de Oliveira GA; Rocha CB; Marques Mde A; Cordeiro Y; Sorenson MM; Foguel D; Silva JL; Suarez MC
Biochemistry; 2013 Jan; 52(1):28-40. PubMed ID: 23215438
[TBL] [Abstract][Full Text] [Related]
37. Effects of high pressure and temperature on the wild-type and F29W mutant forms of the N-domain of avian troponin C.
Yu A; Ballard L; Smillie L; Pearlstone J; Foguel D; Silva J; Jonas A; Jonas J
Biochim Biophys Acta; 1999 Apr; 1431(1):53-63. PubMed ID: 10209279
[TBL] [Abstract][Full Text] [Related]
38. CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90.
Rudiger S; Freund SM; Veprintsev DB; Fersht AR
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11085-90. PubMed ID: 12163643
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.
Nikolova PV; Wong KB; DeDecker B; Henckel J; Fersht AR
EMBO J; 2000 Feb; 19(3):370-8. PubMed ID: 10654936
[TBL] [Abstract][Full Text] [Related]
40. Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.
Poon GM; Brokx RD; Sung M; Gariépy J
J Mol Biol; 2007 Jan; 365(4):1217-31. PubMed ID: 17113101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
